PW Nova Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$450K Sell
18,673
-954
-5% -$25K 0.1% 143
2026
Q1
$551K Buy
19,627
+585
+3% +$15.6K 0.14% 123
2025
Q4
$479K Buy
+19,042
New +$480K 0.18% 78

Other funds holding PFE

PW Nova Financial Services's PFE Position: Q2 2026 in Review

PW Nova Financial Services reduced its Pfizer (PFE) stake by 4.9% in Q2 2026, selling an estimated $25K and leaving 18,673 shares worth $450K. The position accounts for 0.1% of the portfolio, ranked #143.

PW Nova Financial Services first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $551K in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • PW Nova Financial Services held 18,673 shares of Pfizer worth $450K as of Q2 2026.
  • PW Nova Financial Services sold 954 Pfizer shares in Q2 2026, an estimated $25K.
  • Pfizer made up 0.1% of PW Nova Financial Services's portfolio in Q2 2026, its #143 holding.
  • PW Nova Financial Services first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • PW Nova Financial Services's Pfizer position peaked at $551K in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on PW Nova Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.